vs
Side-by-side financial comparison of AGNC Investment Corp. (AGNC) and AdvanSix Inc. (ASIX). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $206.0M, roughly 1.7× AGNC Investment Corp.). AGNC Investment Corp. runs the higher net margin — 463.1% vs -0.8%, a 463.9% gap on every dollar of revenue. On growth, AGNC Investment Corp. posted the faster year-over-year revenue change (79.1% vs 9.4%). Over the past eight quarters, AGNC Investment Corp.'s revenue compounded faster (7.9% CAGR vs 3.4%).
The Russell 1000 Index is a U.S. stock market index that tracks the largest 1,000 stocks in the Russell 3000 Index, which represent about 93% of the total market capitalization of that index. The index is market cap weighted, meaning larger companies have a greater influence on the index than smaller companies.
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
AGNC vs ASIX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $206.0M | $359.9M |
| Net Profit | $954.0M | $-2.8M |
| Gross Margin | — | 7.6% |
| Operating Margin | — | -0.7% |
| Net Margin | 463.1% | -0.8% |
| Revenue YoY | 79.1% | 9.4% |
| Net Profit YoY | 682.0% | -892.9% |
| EPS (diluted) | $0.90 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $206.0M | $359.9M | ||
| Q3 25 | $148.0M | $374.5M | ||
| Q2 25 | $162.0M | $410.0M | ||
| Q1 25 | $159.0M | $377.8M | ||
| Q4 24 | — | $329.1M | ||
| Q3 24 | $-64.0M | $398.2M | ||
| Q2 24 | $-3.0M | $453.5M | ||
| Q1 24 | $-30.0M | $336.8M |
| Q4 25 | $954.0M | $-2.8M | ||
| Q3 25 | $806.0M | $-2.6M | ||
| Q2 25 | $-140.0M | $31.4M | ||
| Q1 25 | $50.0M | $23.3M | ||
| Q4 24 | — | $352.0K | ||
| Q3 24 | $346.0M | $22.3M | ||
| Q2 24 | $-48.0M | $38.9M | ||
| Q1 24 | $443.0M | $-17.4M |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 17.9% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | -0.7% | ||
| Q3 25 | — | -0.9% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | -3.9% | ||
| Q3 24 | — | 7.5% | ||
| Q2 24 | — | 11.5% | ||
| Q1 24 | — | -7.0% |
| Q4 25 | 463.1% | -0.8% | ||
| Q3 25 | 544.6% | -0.7% | ||
| Q2 25 | -86.4% | 7.7% | ||
| Q1 25 | 31.4% | 6.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | -540.6% | 5.6% | ||
| Q2 24 | 1600.0% | 8.6% | ||
| Q1 24 | -1476.7% | -5.2% |
| Q4 25 | $0.90 | $-0.11 | ||
| Q3 25 | $0.72 | $-0.10 | ||
| Q2 25 | $-0.17 | $1.15 | ||
| Q1 25 | $0.02 | $0.86 | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | $0.39 | $0.82 | ||
| Q2 24 | $-0.11 | $1.43 | ||
| Q1 24 | $0.59 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $450.0M | $19.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $12.4B | $815.2M |
| Total Assets | $115.1B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $450.0M | $19.8M | ||
| Q3 25 | $450.0M | $23.7M | ||
| Q2 25 | $656.0M | $18.4M | ||
| Q1 25 | $455.0M | $8.3M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | $507.0M | $17.3M | ||
| Q2 24 | $530.0M | $12.1M | ||
| Q1 24 | $505.0M | $20.6M |
| Q4 25 | $12.4B | $815.2M | ||
| Q3 25 | $11.4B | $818.2M | ||
| Q2 25 | $10.3B | $823.7M | ||
| Q1 25 | $10.0B | $794.4M | ||
| Q4 24 | — | $774.6M | ||
| Q3 24 | $9.7B | $766.4M | ||
| Q2 24 | $8.7B | $746.6M | ||
| Q1 24 | $8.6B | $713.2M |
| Q4 25 | $115.1B | $1.7B | ||
| Q3 25 | $109.0B | $1.7B | ||
| Q2 25 | $102.0B | $1.6B | ||
| Q1 25 | $95.9B | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $89.6B | $1.5B | ||
| Q2 24 | $79.7B | $1.5B | ||
| Q1 24 | $71.9B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $653.0M | $63.7M |
| Free Cash FlowOCF − Capex | — | $36.1M |
| FCF MarginFCF / Revenue | — | 10.0% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | 0.68× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $6.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $653.0M | $63.7M | ||
| Q3 25 | $153.0M | $26.6M | ||
| Q2 25 | $180.0M | $21.1M | ||
| Q1 25 | $192.0M | $11.4M | ||
| Q4 24 | — | $64.2M | ||
| Q3 24 | $7.0M | $57.3M | ||
| Q2 24 | $-20.0M | $50.2M | ||
| Q1 24 | $20.0M | $-36.2M |
| Q4 25 | — | $36.1M | ||
| Q3 25 | — | $66.0K | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | $-22.6M | ||
| Q4 24 | — | $29.8M | ||
| Q3 24 | — | $26.8M | ||
| Q2 24 | — | $16.7M | ||
| Q1 24 | — | $-71.6M |
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | -6.0% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | -21.3% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 10.5% |
| Q4 25 | 0.68× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | 0.67× | ||
| Q1 25 | 3.84× | 0.49× | ||
| Q4 24 | — | 182.29× | ||
| Q3 24 | 0.02× | 2.57× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | 0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGNC
Segment breakdown not available.
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
